Literature DB >> 25636978

[Drug-food interactions in internal medicine: What physicians should know?].

S Mouly1, M Morgand2, A Lopes2, C Lloret-Linares3, J-F Bergmann3.   

Abstract

Orally administered medications may interact with various fruits, vegetables, herbal medicines, functional foods or dietary supplements. Drug-food interactions, which are mostly unknown from prescribers, including internists, may be responsible for changes in drug plasma concentrations, which may decrease efficacy or led to sometimes life-threatening toxicity. Aging, concomitant medications, transplant recipients, patients with cancer, malnutrition, HIV infection and those receiving enteral or parenteral feeding are at increased risk of drug-food interactions. This review focused on the most clinically relevant drug-food interactions, including those with grapefruit juice, Saint-John's Wort, enteral or parenteral nutrition, their respective consequences in the clinical setting in order to provide thoughtful information for internists in their routine clinical practice. Specific clinical settings are also detailed, such as the Ramadan or multiple medications especially in elderly patients. Drug-food interactions are also presented with respect to the main therapeutic families, including the non-steroidal anti-inflammatory drugs, analgesics, cardiovascular medications, warfarin as well as new oral anticoagulants, anticancer drugs and immunosuppressant medications. Considerable effort has been achieved to a better understanding of food-drug interactions and increase clinicians' ability to anticipate their occurrence and consequences in clinical practice. Describing the frequency of relevant food-drug interactions in internal medicine is paramount in order to optimize patient care and drug dosing on an individual basis as well as to increase patients and doctors information.
Copyright © 2015 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Cytochrome P450 3A4; Drug–food interactions; Grapefruit juice; Herbal medicines; Interactions médicament–aliment; Jus de pamplemousse; P-glycoprotein; P-glycoprotéine; Plantes médicinales

Mesh:

Substances:

Year:  2015        PMID: 25636978     DOI: 10.1016/j.revmed.2014.12.010

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  6 in total

1.  Adverse events associated with interactions with dietary and herbal supplements among inpatients.

Authors:  Ilana Levy; Samuel Attias; Eran Ben-Arye; Lee Goldstein; Elad Schiff
Journal:  Br J Clin Pharmacol       Date:  2016-11-25       Impact factor: 4.335

2.  Potential drug interactions with dietary and herbal supplements during hospitalization.

Authors:  Ilana Levy; Samuel Attias; Eran Ben-Arye; Lee Goldstein; Elad Schiff
Journal:  Intern Emerg Med       Date:  2016-10-05       Impact factor: 3.397

3.  Interactions between dietary supplements in hospitalized patients.

Authors:  Ilana Levy; Samuel Attias; Eran Ben Arye; Lee Goldstein; Elad Schiff
Journal:  Intern Emerg Med       Date:  2016-02-02       Impact factor: 3.397

4.  Pharmacokinetic parameters of ifosfamide in mouse pre-administered with grapefruit juice or naringin.

Authors:  Eduardo Madrigal-Bujaidar; Edilberto Pérez-Montoya; Sandra García-Medina; José Melesio Cristóbal-Luna; José A Morales-González; Eduardo Osiris Madrigal-Santillán; Rogelio Paniagua-Pérez; Isela Álvarez-González
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

5.  Interactions of clinical relevance associated with concurrent administration of prescription drug and food or medicinal plants: a systematic review protocol.

Authors:  Adriana Orellana-Paucar; Daniela Vintimilla-Rojas
Journal:  Syst Rev       Date:  2020-01-06

6.  A novel graph mining approach to predict and evaluate food-drug interactions.

Authors:  Md Mostafizur Rahman; Srinivas Mukund Vadrev; Arturo Magana-Mora; Jacob Levman; Othman Soufan
Journal:  Sci Rep       Date:  2022-01-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.